US Top 20: Gilead employees make five times the money
This article was originally published in Scrip
Executive Summary
Gilead is only the fourth biggest North American pharmaceutical company, but each of its employees generates five times more revenue and nearly four times the profit than any of its big rivals. In doing so it is raising a new standard for performance that should have stock analysts and pharmaceutical executives alike rewriting their expectations. And perhaps the Gilead folks should start redrafting their remuneration packages.
You may also be interested in...
Gender Diversity In Pharma: Caught Between Desire And Reality
Charting the executive gender mix across 384 companies from mid-2014 to mid-2019 demonstrates that C-suite gender balance in pharma is moving towards a point that more closely reflects its total workforce, but that progress has been slow and that there is a long road to travel before the transformation is complete.
Women In High Places: Slow Progress In Pharma
With gender diversity only slowly increasing in biopharma c-suites, Scrip spoke to executives from five companies about the importance of change.
Stock Scan April 2018: Pharma's Fizz Falls Flat
In a flat month, the market value of big pharma changed little overall. But the balance of power in immuno-oncology did shift significantly.